Author

Xin Gu

Louisiana State UniversityORCID 0000-0001-7274-1754Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xin Gu1 paper · Sartorius Stedim North America Inc.;

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Amanda Raphael· 1 shared Anish Ashok GuptaiD· 1 shared Celine Asbury· 1 shared Chiachen CheniD· 1 shared Davorka Sekulić· 1 shared Jeyaluxmy Sivalingam· 1 shared Lin KangiD· 1 shared Lin LiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda Raphael

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 31, 2026

INSM1 Regulates Neuroendocrine Plasticity and Tumor Progression in Prostate Cancer

Chiachen Chen, SIYUAN CHENG, Lin Li…·Michael S. Lan

This study identifies INSM1 as a key regulator of neuroendocrine plasticity and tumor progression in prostate cancer, showing its role in lineage programs and identifying HHT as a potential therapeutic agent.

DOI 10.64898/2026.07.30.741780

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 2, 2025

Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants

Md Saqline Mostaq, Mohammad Nurul Amin, Amanda Raphael…·Yu Liu

This study shows that inhibiting glucosylceramide synthase (GCS) re-sensitizes drug-resistant cancer cells with homozygous p53 mutations to chemotherapy and reduces cancer stem cells.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky